NSIX -- Neuromedical Systems, Inc. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : NSIX -- Neuromedical Systems, Inc.

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Pices who wrote (57)	10/28/1997 6:27:00 PM
From: Mason Barge	Read Replies (1) of 137

There is an excellent piece in last week's Fortune about the various difficulties with NSIX and PapNet's acceptance in the medical marketplace. The litigation with the ThinSlide or ThinSmear (or whatever it is) people seems rather silly, and the hospitals apparently already lose money on Pap smears as it is. In other words, there is no financial incentive to them to improve Pap smears if it costs them money, and I guess the insurance companies have made an actuarial decision that it's cheaper for them to pay for treating an extra 100,000 or however-many cases of more advanced cervical cancer than 5 million or 50 million PapNet procedures. It's extremely harsh, but that looks like the problem to me.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next